Altasciences Featured Content

  1. The Complexities Of Early Phase Ophthalmic Drug Development 2/20/2025

    Navigating the landscape of ophthalmic drug development can be challenging. Check out this scientific journal that outlines potential challenges, and how to overcome them.

  2. Factors Affecting Systemic Drug Exposure 1/22/2025

    The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.

  3. The Complexities Of GLP-1 Receptor Agonist Drug Development 11/20/2024

    Review the requirements for successful GLP-1 drug development, including preclinical research approaches, clinical study designs, bioanalytical techniques, and manufacturing challenges.

  4. Toxicokinetics, Pharmacokinetics, And Pharmacodynamics 11/20/2024

    Discover why gathering and analyzing pharmacokinetic (PK) and pharmacodynamic (PD) data is key — from preclinical studies right to clinical trial conduct.

  5. Mental Health: 5 Facts About Psychedelics 10/16/2024

    As mental health issues surge globally, especially following the COVID-19 pandemic, renewed interest in psychedelic drugs is driving research into their potential therapeutic uses.

  6. 5 Ways Integrated Drug Development Solutions Save Time And Money 10/16/2024

    See how this approach can cut research timelines by up to 40%, helping sponsors efficiently navigate early-phase drug development.

  7. How To Optimize Early-Phase Drug Development 10/16/2024

    Do you keep hitting roadblocks? Frustrated with all the paperwork? Let us help! Learn how Altasciences can provide a more seamless and efficient drug development experience.

  8. Metabolic Disorders Clinical Trial Case Study 9/17/2024

    Check out this case study to learn how partnering with an accomplished contract research organization is essential in the complex and dynamic field of metabolic drug development.

  9. Drug-Drug Interaction Study On A Novel Cardiovascular Medication 9/17/2024

    Learn how Altasciences leveraged its expertise to design, recruit, and conduct complex DDI studies, assessing pharmacokinetic and pharmacodynamic impacts of co-administered drugs.

  10. Integrated CNS Drug Development Solutions 5/22/2024

    Understand how early engagement with a fully integrated and experienced CNS drug development partner can accelerate timelines by facilitating continuous data sharing and decision-making.